文章核心观点 公司宣布在2025年美波科技研讨会上展示和讨论其药物Ampligen相关免疫疗法，强调公私合作在癌症研究和治疗开发中的潜力，CEO计划在即将举行的会议上建立欧洲临床合作和潜在许可协议 [1][2][4] 会议信息 - 会议名称为2025年美波科技研讨会，于2025年6月17 - 20日在硅谷、旧金山和斯坦福大学举行 [1] - 会议主题是“奇点中的机遇”，由美波科技研讨会与多家机构合作举办 [3] 药物研究情况 - 世界知名研究肿瘤学家Pawel Kalinski博士展示了涉及公司药物Ampligen的研究，该药物已针对实体瘤、病毒性疾病和免疫系统疾病进行研究 [1][2] - 公司是一家免疫制药公司，专注于治疗多种癌症、免疫疾病和病毒性疾病的疗法研发，主要产品是Ampligen [5] 合作与发展潜力 - Kalinski博士认为公私合作通过联合临床试验开发新疗法有很大潜力，可在美国、波兰及其他中东欧国家拓展 [2] - 公司CEO表示共同努力可加速癌症研究，将在9月波兰华沙的会议上建立政府和行业资助的临床合作及潜在许可协议，重点在波兰 [4] 公司联系方式 - 投资者联系JTC Team, LLC的Jenene Thomas，电话908.824.0775，邮箱AIM@jtcir.com [8][9] 公司官网及社交平台 - 更多信息可访问公司官网aimimmuno.com，并在X、领英和脸书与公司联系 [6]

行业经验 - 拥有30多年跨行业分析经验 涵盖航空 石油 零售 矿业 金融科技和电子商务等多个领域 [1] - 具备宏观经济 货币政策和政治因素对行业影响的分析能力 [1] - 经历过多次重大危机 包括龙舌兰危机 亚洲金融危机 互联网泡沫 911事件 大衰退和新冠疫情 [1] - 具有创业经验 涉及出口 保理和印刷行业 [1] 分析方法 - 专注于企业基本面分析 擅长剖析不同行业的运营机制 [1] - 持续学习并应用经验来理解新技术 创新和商业模式 [1] - 能够将跨领域的经验应用于多学科分析 [1] 注：文档[2][3]内容为披露声明和免责条款 根据任务要求不予总结

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action. Investors have until July 22, 2025, to ask the Court to be appointed to lea ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Reddit, Inc. (NYSE: RDDT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Reddit, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/reddit-inc-securities-fraud-class-action. Investors have until August 18, 2025, to ask the Court to ...

诉讼案件概述 - 领先证券律师事务所Bleichmar Fonti & Auld LLP宣布对Iovance Biotherapeutics公司及其高管提起集体诉讼 指控其违反联邦证券法 [1] - 诉讼依据为《1934年证券交易法》第10(b)和20(a)条款 案件由美国加州北区地方法院受理 案件编号25-cv-04177 [2] - 投资者需在2025年7月14日前申请成为首席原告 [2] 公司业务背景 - Iovance为商业阶段生物制药公司 专注于黑色素瘤及其他实体瘤治疗药物开发 [3] - 核心产品Amtagvi于2024年2月商业化上市 通过授权治疗中心(ATCs)进行给药 [3] 指控核心内容 - 公司被指控虚假宣传ATCs对Amtagvi需求的推动作用 实际存在治疗启动延迟 患者筛选低效导致高脱落率等问题 [4] - 2025年5月8日公司公布不及预期的一季度业绩 并下调全年营收指引 归因于ATCs治疗启动速度不均及患者脱落率高 [5] 市场反应 - 业绩公布次日股价暴跌44% 从5月8日的3 17美元/股跌至5月9日的1 75美元/股 [6] 律所背景 - Bleichmar Fonti & Auld LLP为国际知名证券集体诉讼律所 2023年被ISS SCAS评为全美前五大原告律所 [8] - 近期成功案例包括从特斯拉董事会追偿9亿美元 从Teva制药追偿4 2亿美元 [9]

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Diversified Holdings and Compass Group Diversified Holdings, LLC (NYSE: CODI) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Compass you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/compass-diversified-holdings. Investors ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc. Investors have until July 11, 2025, to ask the Court to be appointed t ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Apple Inc. (NASDAQ: AAPL) and certain of the Company's senior executives for potential violations of the federal securities laws. Why was Apple Sued for Securities Fraud? Apple is a multinational technology company that engages primarily in the businesses of smart-devices and artificial intelligence ("AI"). Apple's software includes a digital personal assistant c ...

With parents and students shifting their demand toward career-focused and tech-based alternatives, LRN's motivation for expanding its focus on career learning and adult certification programs is increasing. Undoubtedly, the company's focal shift is paying off, offering it revenue visibility and profitability prospects in the upcoming period. The robust market trends alongside its diversified career-focused programs resulted in a 33.7% year-over-year enrollment growth in Stride's Career Learning segment duri ...